Pilot & Feasibility Studies are research projects aimed at: 1) attracting more junior investigators of the faculty into the area of diabetes-related type II translational research; 2) allowing more established investigators who are not currently engaged in diabetes type II translational research to extend their investigations into this important area; or 3) permitting any investigator to test a novel hypothesis of relevance to diabetes type II translational research which might not yet meet NIH requirements for R01 or R18 funding. It is strongly anticipated that the results of these pilot projects will eventually permit investigators to compete successfully for more standard sources of research support. The proposed project must be significantly different from funded research already being conducted by the PI. Trainees are not eligible to apply. Collaborations across institutions are strongly encouraged.
Type II diabetes translational research is defined as research focused on translating interventions/approaches into real world health care settings, communities, and populations at risk. Type II translational research might include effectiveness, dissemination, implementation, and cost effectiveness research. The target of this type of the research can be varied to include individuals, families, healthcare practitioners or systems, communities, and/or policy makers. Projects utilizing methods of health services research, public health research, community-based participatory research, cost-effectiveness research and behavioral intervention research are prioritized.
Period and Amount of Funding
Pilot and Feasibility Studies will be funded eight months beginning January 1, 2016. Pilot and Feasibility Studies are funded up to $22,500 in direct costs. Funds may be requested for personnel, supplies, service and other costs, as for any NIH grant application. There is no support for PI salary or indirect costs so they should not be included in the budget. In the spring of 2016, candidates will be notified if there will be an option for a four-month no cost extension for the pilot funding.
Director of the Pilot and Feasibility Grants Program: Arshiya Baig, MD, MPH
Click here to download the most recent request for applications. The next application deadline is October 7, 2015, 5pm CST.
Fall/Winter 2014 Grantees
Chia-Hung (Ed) Chou, PhD, University of Chicago
Diabetes treatments and cancer survival outcomes among women
Xuejie (James) Zhang, PhD, University of Chicago
Patterns of Cost-Related Medication Non-Adherence Among Diabetic Dual Patients
Fall/Winter 2013 Grantees
Pamela Martyn-Nemeth, PhD, RN, University of Illinois at Chicago
Hypoglycemic Fear: Influence on Self‐Management and Glucose Variability in T1DM
Valerie Press, MD, MPH, University of Chicago
EnVISIONeD: Examining VISion among Inpatients with Diabetes
Spring 2013 Grantees
Namratha Kandula, MD, MPH, Northwestern University
Patients’ and Providers’ Perspectives on Metformin for Diabetes Prevention
Milda Saunders, MD, MPH, University of Chicago
Effect of Diabetes in Recognition and Referral of Patients for Pre-ESRD Care
Julie Wagner, PhD, University of Connecticut Health Center
Pilot Study of the Effects of Stress Management on Autonomic Tone in Diabetes
Summer 2012 Grantees
Kristen Knutson, PhD, University of Chicago
Sleep interventions to improve sleep and diabetes risk in African Americans
Neda Laiteerapong, MD, MS, University of Chicago
Ethnic differences in patient beliefs regarding the timing of A1c and blood pressure control
Christine Pellegrini, PhD, Northwestern University
NEAT! Technology to increase breaks in sedentary behavior in adults with diabetes
We ask that any abstracts, presentations, or papers that result from this grant acknowledge the financial support of the Chicago Center for Diabetes Translation Research (NIDDK P30 DK092949) as well as the Dean’s office of the Biological Sciences Division of the University of Chicago, which is generously providing half of the funds for the P&F grant program.